Recent advances in magnetic nanoparticle-based molecular probes for hepatocellular carcinoma diagnosis and therapy

Qi Zhang, Sudan Wang, Ruirui Qiao, Michael R. Whittaker, John F. Quinn, Thomas P. Davis, Hongjun Li

Research output: Contribution to journalReview ArticleResearchpeer-review

2 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, leading to the second most likely cause of cancer-related deaths. Medical imaging is crucial in clinic for HCC screening and diagnosis. Due to the relatively high special resolution and excellent sensitivity, magnetic resonance imaging (MRI) by using magnetic nanoparticle-based contrast agents has been used so far in HCC imaging and staging, demonstrating great potential and promising in vivo applications. This review focuses on the use of different magnetic nanoparticles for construction of HCC nanoprobes for MR imaging and theranostic purpose.

Original languageEnglish
Pages (from-to)2432-2437
Number of pages6
JournalCurrent Pharmaceutical Design
Volume24
Issue number21
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • Cancer
  • Diagnosis
  • Hepatocellular carcinoma
  • Magnetic nanoparticle
  • Molecular imaging
  • Mri

Cite this

@article{840a4e3826614c0faf4af70f9e3a8082,
title = "Recent advances in magnetic nanoparticle-based molecular probes for hepatocellular carcinoma diagnosis and therapy",
abstract = "Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, leading to the second most likely cause of cancer-related deaths. Medical imaging is crucial in clinic for HCC screening and diagnosis. Due to the relatively high special resolution and excellent sensitivity, magnetic resonance imaging (MRI) by using magnetic nanoparticle-based contrast agents has been used so far in HCC imaging and staging, demonstrating great potential and promising in vivo applications. This review focuses on the use of different magnetic nanoparticles for construction of HCC nanoprobes for MR imaging and theranostic purpose.",
keywords = "Cancer, Diagnosis, Hepatocellular carcinoma, Magnetic nanoparticle, Molecular imaging, Mri",
author = "Qi Zhang and Sudan Wang and Ruirui Qiao and Whittaker, {Michael R.} and Quinn, {John F.} and Davis, {Thomas P.} and Hongjun Li",
year = "2018",
month = "1",
day = "1",
doi = "10.2174/1381612824666180516111939",
language = "English",
volume = "24",
pages = "2432--2437",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers",
number = "21",

}

Recent advances in magnetic nanoparticle-based molecular probes for hepatocellular carcinoma diagnosis and therapy. / Zhang, Qi; Wang, Sudan; Qiao, Ruirui; Whittaker, Michael R.; Quinn, John F.; Davis, Thomas P.; Li, Hongjun.

In: Current Pharmaceutical Design, Vol. 24, No. 21, 01.01.2018, p. 2432-2437.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Recent advances in magnetic nanoparticle-based molecular probes for hepatocellular carcinoma diagnosis and therapy

AU - Zhang, Qi

AU - Wang, Sudan

AU - Qiao, Ruirui

AU - Whittaker, Michael R.

AU - Quinn, John F.

AU - Davis, Thomas P.

AU - Li, Hongjun

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, leading to the second most likely cause of cancer-related deaths. Medical imaging is crucial in clinic for HCC screening and diagnosis. Due to the relatively high special resolution and excellent sensitivity, magnetic resonance imaging (MRI) by using magnetic nanoparticle-based contrast agents has been used so far in HCC imaging and staging, demonstrating great potential and promising in vivo applications. This review focuses on the use of different magnetic nanoparticles for construction of HCC nanoprobes for MR imaging and theranostic purpose.

AB - Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, leading to the second most likely cause of cancer-related deaths. Medical imaging is crucial in clinic for HCC screening and diagnosis. Due to the relatively high special resolution and excellent sensitivity, magnetic resonance imaging (MRI) by using magnetic nanoparticle-based contrast agents has been used so far in HCC imaging and staging, demonstrating great potential and promising in vivo applications. This review focuses on the use of different magnetic nanoparticles for construction of HCC nanoprobes for MR imaging and theranostic purpose.

KW - Cancer

KW - Diagnosis

KW - Hepatocellular carcinoma

KW - Magnetic nanoparticle

KW - Molecular imaging

KW - Mri

UR - http://www.scopus.com/inward/record.url?scp=85055656416&partnerID=8YFLogxK

U2 - 10.2174/1381612824666180516111939

DO - 10.2174/1381612824666180516111939

M3 - Review Article

VL - 24

SP - 2432

EP - 2437

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 21

ER -